Alembic Pharma (Alembic Pharma) received FDA approval - Dollar Advisory Financial Services

Breaking

Friday 16 December 2016

Alembic Pharma (Alembic Pharma) received FDA approval

Alembic Pharma (Alembic Pharma) for a new drug has been approved by the USFDA.

 

Company Itrokonajhol capsules (100 mg) for the approvals, which are used to treat fungal infections. The capsule of the total trade in 2015 was 4.2 million.

Alembic Pharma at Rs 617.65 on the BSE on Thursday's closing stock levels higher than they opened at Rs 625.00 and Rs 636.75 climbed as high. At the end of trading, the stock at Rs 4.95, or 0.80%, to close at Rs 622.60 with strong light.


 For more information Call us ✆ +91 7400-73400 or Visit Dollar Advisory

 

No comments:

Post a Comment